2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one
C37H38N2O3 — CID 139672479
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one
2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one (PubChem CID 139672479) has the molecular formula C37H38N2O3 and a molecular weight of 558.72 g/mol. Its IUPAC name is 2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one.
Molecular Properties
| Compound Name | 2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one |
|---|---|
| PubChem CID | 139672479 |
| Molecular Formula | C37H38N2O3 |
| Molecular Weight | 558.72 g/mol |
| Exact Mass | 558.29 |
| IUPAC Name | 2'-anilino-3'-methyl-6'-(2,4,4-trimethyl-3-propylpyrrolidin-1-yl)spiro[2-benzofuran-3,9'-xanthene]-1-one |
| SMILES | CCCC1C(C)N(c2ccc3c(c2)Oc2cc(C)c(Nc4ccccc4)cc2C32OC(=O)c3ccccc32)CC1(C)C |
| InChI | InChI=1S/C37H38N2O3/c1-6-12-28-24(3)39(22-36(28,4)5)26-17-18-30-34(20-26)41-33-19-23(2)32(38-25-13-8-7-9-14-25)21-31(33)37(30)29-16-11-10-15-27(29)35(40)42-37/h7-11,13-21,24,28,38H,6,12,22H2,1-5H3 |
| InChIKey | PEHUKLRAKQALCU-UHFFFAOYSA-N |
| XLogP | 8.96 |
| TPSA | 50.80 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.72 |
| LogP ≤ 5 | 8.96 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139672479 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.